Stryker Corporation (SYK) Stock Score, Valuation & Financial Research
Stryker Corporation is in the Healthcare sector and Medical - Devices industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 37/100.
Quick answer for SYK
Stryker Corporation currently has a Wall Street Score of 37/100. The stored market price is $275.56. Its financial score is 27/100. Its valuation score is 10/100. These figures are a research snapshot, not a buy or sell recommendation.
What Stryker Corporation does
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, caterin
SYK financial snapshot
- Wall Street Score:
- 37/100
- Current price:
- $275.56
- Market capitalization:
- $105.64B
- Revenue:
- $25.27B
- Net income:
- $3.34B
- Free cash flow:
- $4.28B
- Cash:
- $2.88B
- Total debt:
- $15.23B
- EPS:
- 8.49
- P/E ratio:
- 32.5x
- Financial score:
- 27/100
- Valuation score:
- 10/100
- Revenue score:
- 19/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $4.28B, showing positive cash generation.
- The balance sheet shows $2.88B of cash versus $15.23B of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 10/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 27/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research SYK
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.